title: Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma.
authors.affiliation: Plymouth University Schools of Medicine and Dentistry, Plymouth, Devon, UK.
authors.forename: Michelle
authors.initials: M
authors.lastname: Furtado
authors.affiliation: Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Michael L
authors.initials: ML
authors.lastname: Wang
authors.affiliation: Pharmacyclics, Inc., Sunnyvale, CA, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: Munneke
authors.affiliation: Pharmacyclics, Inc., Sunnyvale, CA, USA.
authors.forename: Jesse
authors.initials: J
authors.lastname: McGreivy
authors.affiliation: Pharmacyclics, Inc., Sunnyvale, CA, USA.
authors.forename: Darrin M
authors.initials: DM
authors.lastname: Beaupre
authors.affiliation: Plymouth University Schools of Medicine and Dentistry, Plymouth, Devon, UK. simon.rule@nhs.net.
authors.forename: Simon
authors.initials: S
authors.lastname: Rule
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000077329:Agammaglobulinaemia Tyrosine Kinase; D001853:Bone Marrow / Q000201:enzymology / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D008218:Lymphocytosis / Q000139:chemically induced / Q000209:etiology* / Q000473:pathology; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology*; D010880:Piperidines; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D011505:Protein-Tyrosine Kinases; D000077329:Agammaglobulinaemia Tyrosine Kinase; D000225:Adenine
keywords: bone marrow; bruton tyrosine kinase inhibitor; ibrutinib; lymphocytosis; mantle cell lymphoma